Sort
30,917 grants matching “tumor microenvironment”
The Aged Microenvironment as a Contributor to Carcinogenesis
$285,246Judith Campisi · University Of Washington · U54 · FY2007 · CA
Prostate Oncology
$285,177Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2013 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
$285,169T.-C. Wu · Johns Hopkins University · R01 · FY2013 · CA
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential
$285,153Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2022 · CA
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential
$285,152Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2025 · CA
P-1: Proteosome-directed novel myeloma therapies
$285,079Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2012 · CA
Define the role of REV-ERB in colonic RORgt+ regulatory T cells
$285,000Ye Zheng · Salk Institute For Biological Studies · R21 · FY2023 · AI
Engineered Nanoparticles for Tumor Targeting
$285,000Esmaiel Jabbari · University South Carolina Research Foundation · · FY2009 · ENG
Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution
$284,982Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2016 · CA
Correction of dendritic cells defects in cancer
$284,976Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$284,952Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cyr61-induced breast cancer: Clinical relevance and therapeutic development
$284,919Ruth Lupu · Northshore University Healthsystem · R01 · FY2007 · CA
Targeting the Pro-tumorigenic Microenvironment
$284,892Yves A Declerck · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
Cyr61-induced breast cancer: Clinical relevance and therapeutic development
$284,883Ruth Lupu · Northshore University Healthsystem · R01 · FY2006 · CA
Lipid programs in melanocyte transformation
$284,811Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Project 1
$284,803Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2022 · CA
Regulation of Tumor Associated Macrophages by TGF-beta
$284,801Venkateshwar G Keshamouni · University Of Michigan At Ann Arbor · R01 · FY2008 · CA
Runx2 Organizes Transcriptional Complexes in Nuclear Microenvironments to Support
$284,776Jane B Lian · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · CA
Runx2 Organizes Transcriptional Complexes in Nuclear Microenvironments to Support
$284,774Jane B Lian · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · CA
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$284,759Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Etanercept Therapy in Follicular Lymphoma
$284,749Dana-Farber Cancer Institute · R21 · FY2002 · CA
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
$284,726Michael S Goligorsky · New York Medical College · R01 · FY2010 · DK
IMMUNOTHERAPY
$284,699Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2009 · CA
INTRA-TUMORAL METABOLIC HETEROGENEITY OF CERVICAL CANCER
$284,694Perry Wayne Grigsby · Washington University · R01 · FY2009 · CA
Project 1 Extracellular Vesicles (EVs) Role in GBM Pathobiology
$284,672Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2017 · CA